Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.40    -0.41 (-8.52%)
Bid:
4.40
Ask:
4.50
Spread: 0.10 (2.273%)
Market Cap: £27.45m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

Immupharma News

ImmuPharma says not looking to raise funds
11 Dec 2019

ImmuPharma says not looking to raise funds

(Sharecast News) - AIM-listed specialist drug discovery and development company ImmuPharma insisted on Wednesday that it is not looking to raise funds...

ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise
11 Dec 2019

ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise

ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise

ImmuPharma shares soar as it teams up with Avion on Lupuzor
28 Nov 2019

ImmuPharma shares soar as it teams up with Avion on Lupuzor

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced a licence and development agreement with Avion Pharmaceutica...

Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion
28 Nov 2019

Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion

Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion

ImmuPharma licenses lupus drug Lupuzor to Avion in the United States
28 Nov 2019

ImmuPharma licenses lupus drug Lupuzor to Avion in the United States

LONDON, Nov 28 (Reuters) - British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, ...

ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval
30 Sep 2019

ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval

ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval

Immupharma Study Demonstrates Robust Safety Profile Of Lupuzor
28 Jun 2019

Immupharma Study Demonstrates Robust Safety Profile Of Lupuzor

(Alliance News) - Immupharma PLC on Friday reported analysis of the results from the study of Lupuzor, its lead programme for the potential breakthrou...

ImmuPharma pleased with Lupuzor open-label study results
28 Jun 2019

ImmuPharma pleased with Lupuzor open-label study results

(Sharecast News) - Specialist drug discovery and development company ImmuPharma released the analysis of results from the open-label six month extensi...